DAWN

Day One Biopharmaceuticals, Inc.

15.19 USD
+0.01 (+0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Day One Biopharmaceuticals, Inc. stock is up 6.9% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jan 17:46 19 Apr, 2024 10.00 CALL 100 0
13 Feb 20:52 17 Jan, 2025 15.00 CALL 100 8

About Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc. develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor.